Skip to main content
Clinical Trials/NCT03644082
NCT03644082
Withdrawn
Not Applicable

Computerized Cognitive Training for Patients With Epilepsy

NYU Langone Health1 site in 1 countryDecember 2020
ConditionsEpilepsy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epilepsy
Sponsor
NYU Langone Health
Locations
1
Primary Endpoint
Immediate Memory Index Score
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

This is a study on the effectiveness of computerized cognitive training for treatment of memory disorders in patients with epilepsy. Participants will be recruited from patients referred for neuropsychological assessment through the NYU Comprehensive Epilepsy Center's inpatient and outpatient services. Individuals meeting inclusion criteria will be screened for the presence of memory disturbance (defined by results of neuropsychological testing) and lack of exposure to any previous form of computerized cognitive training. All eligible subjects will be provided with an account for Lumosity with instructions to complete training modules 5 days per week for a total of 8 consecutive weeks. Outcomes will be evaluated through changes on the neuropsychological test battery.

Registry
clinicaltrials.gov
Start Date
December 2020
End Date
April 30, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Documented diagnosis of epilepsy based on medical records. The records will be reviewed by the PI and the approved study personnel to confirm that a diagnosis of epilepsy has been made.
  • Presence of memory disturbance, as defined by an immediate or delayed memory index score \< 85 on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
  • Availability of a home computer and internet for access to the computer training program.

Exclusion Criteria

  • Full Scale IQ \< 80, as assessed by an appropriate Wechsler scale (WAIS-IV or WASI-II).
  • Epilepsy surgery within 8 weeks of the beginning of the trial.
  • History of chronic progressive neurologic or neurodegenerative illnesses (e.g., Alzheimer's disease, multiple sclerosis, primary or metastatic malignancy). Patients with headache or migraine are not excluded.
  • History of Axis I psychiatric illness with psychotic features. (e.g., schizophrenia or bipolar disorder). Patients with depression or anxiety (treated or untreated) without psychotic features are not excluded.
  • Visual or auditory impairment, which precludes participation in part, or all of the testing or computer training.
  • English as a first language will not be required, but participants must have either received some of their schooling in English or used English in their work for \>10 years.
  • Previous exposure (\> one week) to Lumosity or a similar computerized training program.

Outcomes

Primary Outcomes

Immediate Memory Index Score

Time Frame: 12 Months

Score on the Repeatable Battery for the Assessment of Neuro-psychological Status (RBANS) will be used to measure immediate memory

Delayed Memory Index Score

Time Frame: 12 Months

Score on the Repeatable Battery for the Assessment of Neuro-psychological Status (RBANS) will be used to measure immediate memory

Study Sites (1)

Loading locations...

Similar Trials